DAVID Utama hurried towards the black Toyota Alphard parked in the lobby of the Indonesia Health Learning Institute (IHLI) owned by the Bio Farma Group. It was Tuesday afternoon, June 25. David, who had just relinquished his position as Chief Executive Officer (CEO) of Kimia Farma, dressed in a black polo shirt and khaki pants, unlike the other Kimia Farma directors who wore their company uniforms.

Earlier that day, the annual general meeti